Progress
At Recalivape, progress is not merely counted in prototypes or publications—it is defined by each strategic step toward empowering personalized addiction recovery through intelligent, adaptive technology. Every milestone strengthens our commitment to reshaping the future of addiction care.
April — Incorporated Recalivape, setting the vision into motion.
June — Completed AMSTAD V1 prototype, establishing our hardware foundation.
July — Submitted AMSTAD to the James Dyson Award.
August — Upgraded to AMSTAD V2 and selected for the NIH-backed Babson SUD Sprint Program.
September — Named U.S. National Winner of the James Dyson Award for AMSTAD innovation.
January — Joined the MIT SUD Ventures Program; strategically pivoted toward the SMART Module for agile, scalable deployment.
February–April — Prototyped, refined, and bench-tested the SMART Module hardware.
May — Finalized production-ready SMART Module (SleeveSense) hardware.
May–July — Developed and released v1.0 of the SMART companion mobile app.
August — Launching IRB-approved studies at Keck Graduate Institute (KGI) and the Tiep Research Institute (TRI) utilizing SMART prototypes.
The Road Ahead
Our milestones are more than a record of progress—they are the foundation of a new paradigm in addiction recovery. With each study initiated, each device deployed, and each insight gained, Recalivape advances closer to delivering a scalable, real-time personalized recovery platform—meeting individuals where they are and adapting alongside their journey toward health and empowerment.
